News | Pompe’s Circumstance
Dr. Jeffrey Pessin has been awarded $2.5 million from the National Institute of Arthritis and Musculoskeletal and Skin Diseases to study the mechanism of Pompe’s disease. ...more
News | Hypothalamus and Aging - Brain Region May Hold Key
While the search continues for the Fountain of Youth, researchers may have found the body’s “fountain of aging”: the brain region known as the hypothalamus. For the first time, scientists at Albert Ei...more
News | Slowed Signaling Stumps Tumors
Research by Drs. Jonathan Backer, Hashem Dbouk, and collaborators at the Medical Research Council Laboratory of Molecular Biology, in Cambridge, UK, may reveal a novel target for anti-cancer drugs....more
News | An On/Off Switch for Hunger
Einstein researchers have found a molecular explanation for the hunger pangs caused by lack of food. Their discovery could lead to an entirely new way to treat obesity and the type 2 diabetes that oft...more
News | Prominent Neurotoxicologist Michael Aschner, Ph.D. Joins Molecular Pharmacology
Leading neurobiologist Michael Aschner, Ph.D., known for his research on the effect of heavy metals on the brain, will join the faculty of Albert Einstein College of Medicine of Yeshiva University. Dr...more
Why Personalized Medicine Holds Promise for Preventing and Treating Diabetes
Recent Progress Could Lead to More Advances in Identifying Those at High Risk
Monday, January 09, 2012
Einstein Joins the New York Genome Center as Twelfth Institutional Founding Member
Thursday, April 11, 2013
Albert Einstein College of Medicine Announces $500 Million Capital Campaign
Over $400 Million Raised to Date, Including Largest Gift in the College of Medicine's History
Monday, April 15, 2013
Albert Einstein College of Medicine Announces $500 Million Capital Campaign
Over $400 Million Raised to Date, Including Largest Gift in the College of Medicine's History
Thursday, May 02, 2013
FEATURE
FEATURE
Thursday, May 23, 2013